Ovarian cancer vaccine shows promise in trial

Early results of a trial for a new personalized ovarian cancer vaccine offers hope for the large number of patients who relapse after treatment, Medical News Today reported.

Three-quarters of trial patients who received the new two-step immunotherapy appeared to respond to the treatment – one patient achieved complete remission, said researchers from the Perelman School of Medicine at the University of Pennsylvania.

Lead study author Lana Kandalaft, a research assistant professor of Obstetrics and Gynecology and director of clinical development and operations in Penn Medicine's Ovarian Cancer Research Center, is presenting the findings on Wednesday at the AACR 2013 Annual Meeting in Washington DC, according to Medical News Today.

"This immunotherapeutic strategy has two steps - dendritic cell vaccination and adoptive T-cell therapy. This is the first time such a combination immunotherapy approach has been used for patients with ovarian cancer,” said Kandalaft, in a statement.

In the study of 31 patients with recurrent, progressive, stage 3 and 4 ovarian cancer, she and her colleagues report that while vaccination therapy alone showed about a 61 percent clinical benefit, the combination of both therapies showed about a 75 percent benefit, said Medical News Today. The vaccine uses the patient’s own tumor cells to teach her immune system to attack the tumor.

Ovarian cancer is often called a “silent killer” because it is hard to spot in its early stages. Symptoms are often mistaken for other common conditions like bloating, constipation, weight gain and more frequent urination.

By the time it is diagnosed, the chances of survival are not good, Medical News Today reported. In the United States, ovarian cancer causes more than 14,000 deaths per year – and is the fifth-leading cause of cancer deaths among women.

"Given these grim outcomes, there is definitely a vast unmet need for the development of novel, alternate therapies," said Kandalaft.

Comments

"Hard nipples" - areola or nipple skin

Someone once wrote"... when i get really cold, or get goosebumbs all over my body, the whole things really scrunch up, like, my entire areola scrunches itself up into a wrinkled little mound. it looks really weird and ugly, and i haven't ever seen other people's breasts do it. what is wrong with my areola/nipples??" The answer: Well nothing is wrong. This is what my areola does too. It's a normal reaction to the coldness or to irritation / stimulation. The little muscles in the areola do a similar goosebump thing as your other skin can do. People often call this phenomenon "hard nipples". Also note that skin on areola has less feeling or sensation to it than other areas of your body. If the areola was very sensitive, then breastfeeding would probably be quite uncomfortable because the baby pulls and tugs it! The nipples are sensitive but the sensitivity changes with hormonal changes, such as occur at mestrual cycle or pregnancy. Also this v...

Mastectomy Drain Breast Cancer Treatment

The purpose of drains after mastectomy is to drain away the fluid that can gather in the armpit region or around the scar on the chest wall. Some people after mastectomy also find that fluid gathers around the shoulder blade area on their back - this seems more common if the muscle from the back has been used for breast reconstruction at the time the mastectomy was done. When mastectomy is done - and especially if the lymph nodes are removed from the axilla or armpit - then there is a lot of tissue fluid and lymph fluid left with no where to go. This fluid normally flows through the lymph channels but if they are cut then it can escape into the normal skin and muscle tissues. Your surgeon will place drains under your skin after mastectomy. These drains gather up the fluid and remove it to a bottle (or bottles) that you carry around with you. Some people use a belt clip to attach the drain to their waistband - making them more mobile. Others car...

Pancreatic Cancer breakthrough

Published Today By Ana Sandoiu Fact checked by Jasmin Collier New research now published in the Journal of Natural Products shows that a vine compound is highly effective in the fight against treatment-resistant pancreatic cancer cells. #cancer #cells #pancreaticcancer #breakthrough #natural #journalofnaruralproducts #cure #survivor #iamstillawoman #Anasandiou #jasmincollier A type of rainforest vine may hold the key to effective cancer treatments. Pancreatic cancer is notoriously difficult to treat, and the condition has a poor outlook. According to the American Cancer Society (ACS), the 5-year survival rate for people with early-stage exocrine pancreatic cancer is 12–14 percent . A new study explains why that is and offers a potential solution. Gerhard Bringmann, a professor of organic chemistry at the Julius-Maximilians-Universität Würzburg in Germany. Specifically, human pancreatic ...

I am still a woman - Confessions of a twice cancer survivor - my journey by Nina Ann McCurley

Search This Blog